US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist

0.2396
-0.0084-3.39%

Close Oct 18 16:00 ET

0.2318
-0.0078-3.26%

Post 20:01 ET

3.20MMarket Cap-237P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(Q4)Jun 30, 2024

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

4.08%-6.99M

-56.42%-1.03M

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

53.26%-7.28M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

15.01%-2.26M

Net income from continuing operations

3.42%-7.68M

-472.61%-1.94M

13.77%-1.72M

29.65%-1.48M

27.73%-2.54M

57.27%-7.95M

95.70%-338.39K

42.52%-2M

50.94%-2.1M

-18.12%-3.51M

Operating gains losses

936.52%12.26K

1,110.99%9.66K

5,717.24%1.63K

-65.34%-1.04K

-27.83%2.02K

-90.99%1.18K

-165.50%-955

96.01%-29

-105.65%-629

121.55%2.8K

Depreciation and amortization

1.43%604.52K

0.59%151.86K

1.02%150.69K

3.56%152.61K

0.58%149.36K

16.45%596K

-2.00%150.97K

-2.71%149.16K

-1.74%147.36K

172.80%148.51K

Other non cash items

-55.67%-1.25K

105.11%21

-1,069.23%-252

-61.41%-481

-348.33%-538

-100.06%-803

-100.03%-411

--26

---298

99.31%-120

Change In working capital

34.73%-369.34K

352.62%665.61K

-395.36%-418.82K

16.90%-709.77K

-77.16%93.65K

81.59%-565.82K

80.85%-263.48K

106.39%141.8K

-340.14%-854.16K

143.64%410.02K

-Change in receivables

57.82%-92.44K

-29.85%-145.16K

286.33%165.19K

-126.09%-207.02K

29.77%94.55K

-447.76%-219.15K

-539.79%-111.79K

-337.79%-88.65K

-14,451.57%-91.56K

2,592.58%72.86K

-Change in inventory

-88.29%66.22K

-399.09%-92.78K

-258.38%-449.11K

31.98%217.78K

187.94%390.33K

128.23%565.56K

98.26%-18.59K

165.71%283.58K

132.89%165.02K

--135.56K

-Change in prepaid assets

-93.22%20.28K

174.35%540.94K

-28.42%94.29K

-90.95%-897.96K

-35.76%283.02K

56.92%299.19K

-61.66%197.17K

111.25%131.73K

-320.82%-470.27K

-30.56%440.56K

-Change in payables and accrued expense

105.61%45.28K

312.82%470.73K

-36.45%-104.34K

169.04%241.38K

-253.19%-562.48K

0.62%-806.53K

64.12%-221.19K

84.44%-76.47K

-145.66%-349.61K

66.06%-159.26K

-Change in other current assets

-10.88%4.91K

--0

--1.79K

-43.38%3.12K

108.96%5.51K

--0

-8.67%5.51K

-Change in other current liabilities

6.83%-397.42K

0.88%-108.12K

11.24%-96.19K

12.76%-94.4K

2.17%-98.71K

-24.78%-426.58K

0.13%-109.09K

-0.81%-108.38K

---108.21K

---100.9K

-Change in other working capital

-200.00%-16.17K

--0

---28.66K

5,984.08%28.66K

-203.00%-16.17K

414.49%16.17K

--0

--471

--15.7K

Cash from discontinued investing activities

Operating cash flow

4.08%-6.99M

-56.42%-1.03M

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

53.26%-7.28M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

15.01%-2.26M

Investing cash flow

Cash flow from continuing investing activities

98.60%-9.29K

100.00%-2

98.14%-9.29K

1.66%-661.8K

95.37%-33.61K

-3,508.16%-128.2K

-263.39%-500K

Net PPE purchase and sale

94.26%-9.29K

--0

100.00%-2

----

-313.74%-161.8K

---33.61K

-3,508.16%-128.2K

----

Net business purchase and sale

--0

----

-139.36%-500K

--0

----

Net investment purchase and sale

--0

Cash from discontinued investing activities

Investing cash flow

98.60%-9.29K

--0

100.00%-2

98.14%-9.29K

--0

1.66%-661.8K

95.37%-33.61K

-3,508.16%-128.2K

-263.39%-500K

--0

Financing cash flow

Cash flow from continuing financing activities

-56.42%4.65M

176

-12.44%4.65M

-29.13%10.68M

-117.31%-63.7K

735.69%5.32M

-50.12%5.43M

Net common stock issuance

-56.42%4.65M

100.15%1

--0

-1.90%4.65M

--0

-37.71%10.68M

-100.01%-646

---63.7K

2,695,346.59%4.74M

-50.00%6M

Proceeds from stock option exercised by employees

-72.91%175

----

--646

----

Net other financing activities

----

48.77%-571.26K

Cash from discontinued financing activities

Financing cash flow

-56.42%4.65M

--176

--0

-12.44%4.65M

--0

-29.13%10.68M

--0

-117.31%-63.7K

735.69%5.32M

-50.12%5.43M

Net cash flow

Beginning cash position

44.29%8.91M

-20.86%7.6M

-16.74%9.53M

-27.94%6.74M

44.29%8.91M

-16.11%6.18M

62.83%9.6M

1.53%11.45M

-39.06%9.35M

-16.11%6.18M

Current changes in cash

-185.57%-2.34M

-48.80%-1.03M

-4.64%-1.93M

33.04%2.8M

-168.51%-2.17M

330.61%2.74M

-348.26%-691.54K

65.65%-1.85M

151.73%2.1M

-60.23%3.17M

End cash Position

-26.27%6.57M

-20.86%7.6M

-16.74%9.53M

-27.94%6.74M

44.29%8.91M

62.83%9.6M

1.53%11.45M

-39.06%9.35M

Free cash flow

6.04%-7M

-48.82%-1.03M

-8.38%-1.93M

31.54%-1.86M

3.61%-2.17M

52.35%-7.45M

82.91%-691.54K

66.65%-1.78M

23.99%-2.71M

15.01%-2.26M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Jun 30, 2024	(Q4)Jun 30, 2024	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	4.08%-6.99M	-56.42%-1.03M	-16.76%-1.93M	31.88%-1.85M	3.61%-2.17M	53.26%-7.28M	83.74%-657.93K	69.03%-1.66M	23.22%-2.71M	15.01%-2.26M
Net income from continuing operations	3.42%-7.68M	-472.61%-1.94M	13.77%-1.72M	29.65%-1.48M	27.73%-2.54M	57.27%-7.95M	95.70%-338.39K	42.52%-2M	50.94%-2.1M	-18.12%-3.51M
Operating gains losses	936.52%12.26K	1,110.99%9.66K	5,717.24%1.63K	-65.34%-1.04K	-27.83%2.02K	-90.99%1.18K	-165.50%-955	96.01%-29	-105.65%-629	121.55%2.8K
Depreciation and amortization	1.43%604.52K	0.59%151.86K	1.02%150.69K	3.56%152.61K	0.58%149.36K	16.45%596K	-2.00%150.97K	-2.71%149.16K	-1.74%147.36K	172.80%148.51K
Other non cash items	-55.67%-1.25K	105.11%21	-1,069.23%-252	-61.41%-481	-348.33%-538	-100.06%-803	-100.03%-411	--26	---298	99.31%-120
Change In working capital	34.73%-369.34K	352.62%665.61K	-395.36%-418.82K	16.90%-709.77K	-77.16%93.65K	81.59%-565.82K	80.85%-263.48K	106.39%141.8K	-340.14%-854.16K	143.64%410.02K
-Change in receivables	57.82%-92.44K	-29.85%-145.16K	286.33%165.19K	-126.09%-207.02K	29.77%94.55K	-447.76%-219.15K	-539.79%-111.79K	-337.79%-88.65K	-14,451.57%-91.56K	2,592.58%72.86K
-Change in inventory	-88.29%66.22K	-399.09%-92.78K	-258.38%-449.11K	31.98%217.78K	187.94%390.33K	128.23%565.56K	98.26%-18.59K	165.71%283.58K	132.89%165.02K	--135.56K
-Change in prepaid assets	-93.22%20.28K	174.35%540.94K	-28.42%94.29K	-90.95%-897.96K	-35.76%283.02K	56.92%299.19K	-61.66%197.17K	111.25%131.73K	-320.82%-470.27K	-30.56%440.56K
-Change in payables and accrued expense	105.61%45.28K	312.82%470.73K	-36.45%-104.34K	169.04%241.38K	-253.19%-562.48K	0.62%-806.53K	64.12%-221.19K	84.44%-76.47K	-145.66%-349.61K	66.06%-159.26K
-Change in other current assets	-10.88%4.91K	--0	--0	--1.79K	-43.38%3.12K	108.96%5.51K	--0	--0	--0	-8.67%5.51K
-Change in other current liabilities	6.83%-397.42K	0.88%-108.12K	11.24%-96.19K	12.76%-94.4K	2.17%-98.71K	-24.78%-426.58K	0.13%-109.09K	-0.81%-108.38K	---108.21K	---100.9K
-Change in other working capital	-200.00%-16.17K	--0	---28.66K	5,984.08%28.66K	-203.00%-16.17K	414.49%16.17K	--0	--0	--471	--15.7K
Cash from discontinued investing activities
Operating cash flow	4.08%-6.99M	-56.42%-1.03M	-16.76%-1.93M	31.88%-1.85M	3.61%-2.17M	53.26%-7.28M	83.74%-657.93K	69.03%-1.66M	23.22%-2.71M	15.01%-2.26M
Investing cash flow
Cash flow from continuing investing activities	98.60%-9.29K	0	100.00%-2	98.14%-9.29K	0	1.66%-661.8K	95.37%-33.61K	-3,508.16%-128.2K	-263.39%-500K	0
Net PPE purchase and sale	94.26%-9.29K	--0	100.00%-2	----	----	-313.74%-161.8K	---33.61K	-3,508.16%-128.2K	----	----
Net business purchase and sale	--0	--0	--0	----	----	-139.36%-500K	--0	--0	----	----
Net investment purchase and sale	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	98.60%-9.29K	--0	100.00%-2	98.14%-9.29K	--0	1.66%-661.8K	95.37%-33.61K	-3,508.16%-128.2K	-263.39%-500K	--0
Financing cash flow
Cash flow from continuing financing activities	-56.42%4.65M	176	0	-12.44%4.65M	0	-29.13%10.68M	0	-117.31%-63.7K	735.69%5.32M	-50.12%5.43M
Net common stock issuance	-56.42%4.65M	100.15%1	--0	-1.90%4.65M	--0	-37.71%10.68M	-100.01%-646	---63.7K	2,695,346.59%4.74M	-50.00%6M
Proceeds from stock option exercised by employees	-72.91%175	----	----	----	----	--646	----	----	----	----
Net other financing activities	----	----	----	----	----	----	----	----	----	48.77%-571.26K
Cash from discontinued financing activities
Financing cash flow	-56.42%4.65M	--176	--0	-12.44%4.65M	--0	-29.13%10.68M	--0	-117.31%-63.7K	735.69%5.32M	-50.12%5.43M
Net cash flow
Beginning cash position	44.29%8.91M	-20.86%7.6M	-16.74%9.53M	-27.94%6.74M	44.29%8.91M	-16.11%6.18M	62.83%9.6M	1.53%11.45M	-39.06%9.35M	-16.11%6.18M
Current changes in cash	-185.57%-2.34M	-48.80%-1.03M	-4.64%-1.93M	33.04%2.8M	-168.51%-2.17M	330.61%2.74M	-348.26%-691.54K	65.65%-1.85M	151.73%2.1M	-60.23%3.17M
End cash Position	-26.27%6.57M	-26.27%6.57M	-20.86%7.6M	-16.74%9.53M	-27.94%6.74M	44.29%8.91M	44.29%8.91M	62.83%9.6M	1.53%11.45M	-39.06%9.35M
Free cash flow	6.04%-7M	-48.82%-1.03M	-8.38%-1.93M	31.54%-1.86M	3.61%-2.17M	52.35%-7.45M	82.91%-691.54K	66.65%-1.78M	23.99%-2.71M	15.01%-2.26M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data